[go: up one dir, main page]

LU90907I2 - Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin) - Google Patents

Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)

Info

Publication number
LU90907I2
LU90907I2 LU90907C LU90907C LU90907I2 LU 90907 I2 LU90907 I2 LU 90907I2 LU 90907 C LU90907 C LU 90907C LU 90907 C LU90907 C LU 90907C LU 90907 I2 LU90907 I2 LU 90907I2
Authority
LU
Luxembourg
Prior art keywords
foscan
temoporfin
pharmaceutically acceptable
acceptable derivatives
same
Prior art date
Application number
LU90907C
Other languages
English (en)
Original Assignee
Bioscience Technology Invest H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscience Technology Invest H filed Critical Bioscience Technology Invest H
Publication of LU90907I2 publication Critical patent/LU90907I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
LU90907C 1988-03-11 2002-04-10 Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin) LU90907I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805849A GB8805849D0 (en) 1988-03-11 1988-03-11 Porphyrins & cancer treatment

Publications (1)

Publication Number Publication Date
LU90907I2 true LU90907I2 (fr) 2003-04-30

Family

ID=10633278

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90907C LU90907I2 (fr) 1988-03-11 2002-04-10 Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)

Country Status (17)

Country Link
US (1) US4992257A (fr)
EP (1) EP0337601B1 (fr)
JP (1) JP2785033B2 (fr)
KR (1) KR970011392B1 (fr)
AT (1) ATE89002T1 (fr)
AU (1) AU611774C (fr)
BR (1) BR1100662A (fr)
CA (1) CA1338737C (fr)
DE (2) DE68906301T2 (fr)
ES (1) ES2055038T3 (fr)
GB (1) GB8805849D0 (fr)
HK (1) HK129693A (fr)
IE (1) IE63290B1 (fr)
LU (1) LU90907I2 (fr)
NL (1) NL300089I2 (fr)
NZ (1) NZ228225A (fr)
ZA (1) ZA891653B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
AU679016B2 (en) * 1992-11-20 1997-06-19 University Of British Columbia, The Method of activating photosensitive agents
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH07233065A (ja) * 1993-12-27 1995-09-05 Canon Inc ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
WO1996040223A1 (fr) * 1995-06-07 1996-12-19 Duke University Epurateurs d'oxydants
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
DE69718268D1 (de) 1996-10-03 2003-02-13 Canon Kk Verfahren zur Detektion von Zielnukleinsäure, Verfahren zu ihrer Quantifizierung und Pyrylium-Verbindungen zur Chemilumineszenz-Analyse
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
DE19814405C2 (de) 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
DE69928655T2 (de) 1998-04-24 2006-08-24 Duke University Substituierte porphyrine
WO2000012512A1 (fr) * 1998-08-28 2000-03-09 Destiny Pharma Limited Derives porphyrine, leur utilisation en therapie photodynamique, et dispositifs medicaux les contenant
DK1155019T3 (da) 1999-01-25 2006-04-18 Nat Jewish Med & Res Center Substituerede porphyriner og deres terapeutiske anvendelse
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
GB0001455D0 (en) 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
EP1392328B1 (fr) 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament pour la protection dans la therapie radiologique
EP1439842A4 (fr) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Capteurs oxydants destines au traitement du diabete ou a etre utilises dans une transplantation ou a induire une tolerance immunitaire
DE60209799T2 (de) 2001-12-03 2007-01-25 Ekos Corp., Bothell Katheter mit mehreren ultraschall-abstrahlenden teilen
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
EP1513537A4 (fr) 2002-06-07 2006-09-06 Univ Duke Porphyrines substituees
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
CA2437638A1 (fr) 2003-08-20 2005-02-20 John Robert North Therapie photodynamique
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
CA2457214A1 (fr) 2004-02-06 2005-08-06 Qlt Inc. Therapie photodynamique pour le traitement de l'acne
ES2400566T3 (es) 2004-06-09 2013-04-10 Qlt, Inc. Terapia fotodinámica para el tratamiento de trastornos de glándulas sebáceas hiperactivas que utiliza verteporfina y/o lemuteporfina aplicadas tópicamente
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
DE102005015286A1 (de) * 2005-04-04 2006-10-05 Tetrapdt Gmbh Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
WO2009002881A1 (fr) 2007-06-22 2008-12-31 Ekos Corporation Procédé et appareil pour le traitement d'hémorragies intracrâniennes
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
WO2009079415A1 (fr) * 2007-12-14 2009-06-25 Ekos Corporation Détermination d'impulsions ultrasonores
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
US9315510B2 (en) 2008-09-18 2016-04-19 Biolitec Pharma Marketing Ltd Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
AU2012205410A1 (en) 2011-01-13 2013-08-01 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
BR112015000383A2 (pt) 2012-07-11 2017-06-27 Dermira Inc composição farmacêutica, e, métodos para preparação de uma composição farmacêutica, para reduzir a taxa de excreção de sebo das glândulas sebáceas na pele de um indivíduo e para tratamento da acne
US9550072B2 (en) 2012-08-03 2017-01-24 Cerca Solutions, LLC Diagnostic device, therapeutic device, and uses thereof
WO2016051361A1 (fr) 2014-09-30 2016-04-07 Biolitec Unternehmensbeteiligungs Ii Ag Porphyrines et chlores méso-substitués de façon spécifique pour la thérapie photodynamique
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
EP3894421A1 (fr) 2018-12-10 2021-10-20 Universität Hamburg Porphyrines et chlorines glyco-substituées de façon spécifique pour une thérapie photodynamique
WO2022074014A1 (fr) 2020-10-05 2022-04-14 Biolitec Unternehmensbeteiligungs Ii Ag Composés à base de tétrapyrrole et leurs formulations pour une thérapie antimicrobienne

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740794A (en) * 1954-07-26 1956-04-03 Exxon Research Engineering Co Synthesis of novel vanadium porphyrin
US3076813A (en) * 1957-11-13 1963-02-05 Monsanto Chemicals alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) * 1981-01-05 1982-05-18 Western Electric Company, Inc. Encapsulated electronic devices and encapsulating compositions
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments

Also Published As

Publication number Publication date
US4992257A (en) 1991-02-12
AU611774B2 (en) 1991-06-20
HK129693A (en) 1993-12-03
DE10299012I1 (de) 2002-07-18
BR1100662A (pt) 1999-10-13
AU611774C (en) 2002-02-21
NL300089I2 (nl) 2002-08-01
JPH01275528A (ja) 1989-11-06
NL300089I1 (nl) 2002-07-01
GB8805849D0 (en) 1988-04-13
IE890687L (en) 1989-09-11
NZ228225A (en) 1990-08-28
DE68906301T2 (de) 1993-09-30
DE68906301D1 (de) 1993-06-09
IE63290B1 (en) 1995-04-05
KR890014548A (ko) 1989-10-24
ATE89002T1 (de) 1993-05-15
CA1338737C (fr) 1996-11-26
EP0337601A1 (fr) 1989-10-18
ZA891653B (en) 1989-11-29
KR970011392B1 (ko) 1997-07-10
AU3097589A (en) 1989-09-14
EP0337601B1 (fr) 1993-05-05
DE10299012I2 (de) 2004-05-06
JP2785033B2 (ja) 1998-08-13
ES2055038T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
LU90907I2 (fr) Foscan et ses dérivés pharmaceutiquement acceptables (temoporfin)
AU578329B2 (en) Anti cancer treatment with porphyrins
DE3576823D1 (de) Infrarot-absorber.
DK1063234T3 (da) Hydrofobe taxanderivater
NL300241I1 (nl) Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines.
ES2137386T3 (es) Derivados del 2-oxindol como inhibidores de la tirosina quinasa.
NO930774L (no) Baccatin-iii-derivater
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
IN170909B (fr)
ATE101601T1 (de) Fluorhaltige nitrazol-derivate und diese umfassender strahlungssensibilisator.
AU2359392A (en) Dihydropyridine derivatives useful in antitumor therapy
ATE170861T1 (de) Antibiotische carbapenemderivate
GR852762B (fr)